Ocugen Inc (NASDAQ:OCGN)

6.60
BATS BZX Real-Time Price
As of 1:30pm ET
 +0.12 / +1.85%
Today’s Change
0.28
Today|||52-Week Range
18.77
+260.66%
Year-to-Date
3 Small-Cap COVID Stocks With Huge Upside
Nov 25 / MotleyFool.com - Paid Partner Content
The Biggest Problem With Moderna Has Nothing to Do With Its Recent Earnings Miss
Nov 18 / MotleyFool.com - Paid Partner Content
Better Buy: Ocugen or Novavax?
Nov 24 / MotleyFool.com - Paid Partner Content
Why This Meme Stock Isn't Worth the Trouble
Nov 18 / MotleyFool.com - Paid Partner Content
Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen
Nov 21 / MotleyFool.com - Paid Partner Content
3 Biotech Stocks That Have More Than Tripled so far This Year
Nov 18 / MotleyFool.com - Paid Partner Content
Ocugen Stock: Bull vs. Bear
Nov 20 / MotleyFool.com - Paid Partner Content
3 Things About Ocugen That Smart Investors Know
Nov 17 / MotleyFool.com - Paid Partner Content
Why Ocugen Shot 8% Higher on Friday
Nov 19 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close6.48
Today’s open6.73
Day’s range6.43 - 6.74
Volume309,148
Average volume (3 months)26,657,476
Market cap$1.3B
Data as of 1:30pm ET, 11/29/2021

Growth & Valuation

Earnings growth (last year)+78.98%
Earnings growth (this year)+3.23%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales4,819.15
Price/Book54.91

Competitors

 Today’s
change
Today’s
% change
RGNXRegenxbio Inc-0.01-0.03%
QUREUniqure NV+0.13+0.45%
SGMOSangamo Therapeutics...-0.03-0.35%
MORMorphoSys AG+0.14+1.41%
Data as of 1:30pm ET, 11/29/2021

Financials

Next reporting dateApril 1, 2022
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$42.6K
Annual profit (last year)-$21.8M
Net profit margin-51,201.20%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Malvern, Pennsylvania

Forecasts